LivaNova PLC Restructuring and Related Cost, Expected Cost Remaining
LivaNova PLC (LIVN) had Restructuring and Related Cost, Expected Cost Remaining of $10.00 million as of 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1 · last filed 2025-02-25
- 2024-12-31: Restructuring and Related Cost, Expected Cost Remaining $10.00M.
- 2023-12-31: Restructuring and Related Cost, Expected Cost Remaining $10.00M.
- 2022-12-31: Restructuring and Related Cost, Expected Cost Remaining $10.00M.
- 2022-09-30: Restructuring and Related Cost, Expected Cost Remaining $10.00M.
| Period end | Restructuring and Related Cost, Expected Cost Remaining |
|---|---|
| 2024-12-31 | $10.00M 10-K · filed 2025-02-25 |
| 2023-12-31 | $10.00M 10-K · filed 2024-02-29 |
| 2022-12-31 | $10.00M 10-K · filed 2023-02-27 |
| 2022-09-30 | $10.00M 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |